This page lists all pharmaceutical reports related to the field of Immunology & Inflammatory Diseases. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 177 results
- World Respiratory Disorders Market 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- World Neurodegenerative Diseases Market 2009-2024
- Rx to OTC Switches 2009
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- The World Dermatological Market Outlook 2010-2024
- Global Pharmaceutical Biotech Market 2010-2025
- The Rheumatoid Arthritis Market: Competitive Landscape and Clinical Stage Analysis
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Allergic Rhinitis - Drug Pipeline Analysis and Market Forecasts to 2016
- The Market for Prescription Dermatological Drugs
- Idiopathic Pulmonary Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Home Healthcare Equipment Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis
- The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues
- The Worldwide Over-the-Counter (OTC) Drug Market
- Global Multiple Sclerosis Drug Market 2010-2025
- World Ophthalmic Pharmaceutical Market 2010-2025
- Multiple Sclerosis - Drug Pipeline Analysis and Market Forecasts to 2015
- Psoriasis - Drug Pipeline Analysis and Market Forecasts to 2015
- Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
- Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
- Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
- Respiratory Devices Global Market Briefing to 2016
- US Pharmaceutical Market Outlook 2011-2021
- Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
- Inflammatory Bowel Disease: World Market 2010-2025
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
- The Future of In Vitro and In Vivo Diagnostic Integration
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2011
- Stakeholder Insight: Rheumatoid arthritis
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy
- R&D Trends: Multiple Sclerosis (MS) - Progressive subtypes remain underserved in expansive pipeline
- UpdatesPlus Nicotinic Receptors and Addiction - Current Research and Development - April/May 2011